Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr, Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr
Abstract
Background: Ketamine rapidly improves depressive symptoms in patients with treatment-resistant major depressive disorder (MDD) who do not respond to multiple standard antidepressants. However, it remains unknown whether ketamine is equally effective in patients with MDD who previously also did not respond to electroconvulsive therapy (ECT).
Methods: This study compared 17 patients with treatment-resistant MDD who previously did not respond to ECT and 23 patients with treatment-resistant MDD who had not previously received ECT. All subjects received a single open-label infusion of ketamine (0.5 mg/kg). Patients were evaluated using the Montgomery-Asberg Depression Rating Scale (MADRS) at baseline (60 min before the infusion), as well as at 40, 80, 120, and 230 min after infusion.
Results: Depressive symptoms were significantly improved in the ECT-resistant group at 230 minutes with a moderate effect size (p < .001, d = 0.50, 95% C.I.: 0.21-0.80). At 230 minutes, the non-ECT exposed group showed significant improvement with a large effect size (p < .001, d=1.00, 95% C.I.: 0.71-1.29).
Conclusion: Ketamine appears to improve depressive symptoms in patients with MDD who had previously not responded to ECT. These preliminary results encourage further investigation with a larger sample size to determine effectiveness compared to other treatment-resistant patients with MDD.
Published by Elsevier Inc.
Figures


Source: PubMed
Prossimi studi clinici
-
University of LahoreNon ancora reclutamentoCondizioni cardiometabolichePakistan
-
Beijing Tiantan HospitalNon ancora reclutamentoAcute and Chronic Postsurgical Pain
-
Instituto de Investigación Sanitaria de la Fundación...ReclutamentoAccesso vascolare | Complicazione dell'accesso vascolare | Dispositivi di accesso vascolareSpagna
-
Liverpool John Moores UniversityReclutamentoIpossia | Caffeina | Placebo – ControlloRegno Unito
-
Democritus University of ThraceReclutamentoFeasibility of Occupation-Based Immersive Virtual Reality for Upper-Limb Rehabilitation After StrokeIctus | Paresi degli arti superioriGrecia
-
Cedars-Sinai Medical CenterNon ancora reclutamentoPreterm Prelabor Rottura delle membrane (PPROM)Stati Uniti
-
Zheng LiNon ancora reclutamento
-
Gwangju Health UniversityReclutamentoGiovane adulto | Instabilità cronica della caviglia, CAICorea del Sud
-
Hospital Universitari Joan XXIII de Tarragona.Institut Investigacio Sanitaria Pere VirgiliNon ancora reclutamentoArtrosi al ginocchio | Dolore cronico al ginocchioSpagna
-
HealthPartners InstituteReclutamentoLesione cerebrale traumatica lieve | Commozione cerebrale (diagnosi)Stati Uniti
-
Fudan UniversityNon ancora reclutamento